To treat or not to treat very elderly naïve patients with atrial fibrillation with vitamin K antagonists (VKA): results from the VENPAF cohort

Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD

(2014) Z. Harel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

2013 ESC guidelines on the management of stable coronary artery disease

(2013)   EUROPEAN HEART JOURNAL

Diabetes is an independent risk factor for peptic ulcer bleeding: A nationwide population-based cohort study

(2013) Yen-Ling Peng et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

STROKE AND BLEEDING IN OLDER PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN

(2013) Meytal Avgil Tsadok et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPACE

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

(2012) et al.   EUROPEAN HEART JOURNAL

New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures

(2012) Sergio Coccheri et al.   Internal and Emergency Medicine

To anticoagulate or not to anticoagulate? That is the question

(2012) Simone Birocchi et al.   Internal and Emergency Medicine

Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes

(2012) Giorgia De Berardis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Bleeding Risk in Very Old Patients on Vitamin K Antagonist Treatment

(2011) Daniela Poli et al.   CIRCULATION

Bleeding in Very Old Patients on Vitamin K Antagonist Therapy

(2011) Jack Ansell   CIRCULATION

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical outcome in Japanese elderly patients with non-valvular atrial fibrillation taking warfarin: A single-center observational study

(2011) Miyoko Naganuma et al.   THROMBOSIS RESEARCH

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Age as a Risk Factor for Stroke in Atrial Fibrillation Patients

(2010) Ricarda Marinigh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lower versus standard intensity oral anticoagulant therapy (OAT) in elderly warfarin-experienced patients with non-valvular atrial fibrillation

(2010) Umberto Cucchini et al.   THROMBOSIS AND HAEMOSTASIS

Bleeding Risk During Oral Anticoagulation in Atrial Fibrillation Patients Older Than 80 Years

(2009) Daniela Poli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE